EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Centers for Medicare and Medicaid Services and others misunderstand stool testing for colorectal cancer

Gloria D Coronado iD, Richard M Hoffman iD, Josheili Llavona-Ortiz iD, Carolyn M Rutter iD

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djaf341 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Gloria D Coronado und 3 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Biostatistics, University of Arizona College of Public Health, and University of Arizona Cancer Center, Tucson, AZ, United States. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Centers for Medicare and Medicaid Services, U.S., Early Detection of Cancer, Feces. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIMHD NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The May 2021 Centers for Medicare and Medicaid Services (CMS) coverage determination allowed reimbursement for blood-based biomarker tests and other tests for colorectal cancer screening that meet minimum 74% sensitivity and 90% specificity thresholds. However, these performance benchmarks fail to account for the importance of detecting precancerous lesions and the impact of the recommended testing interval on the effectiveness of screening. We review the limitations of the CMS criteria, summarize supporting evidence for stool-based testing and colonoscopy as effective and cost-efficient screening modalities, and offer recommendations to strengthen CMS coverage decisions to better align with public health goals in colorectal cancer prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCenters for Medicare and Medicaid Services, U.S.Early Detection of CancerFecesHumansUnited StatesColonoscopyBiomarkers, TumorOccult BloodSensitivity and SpecificityMass Screening

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Epidemiology and Biostatistics, University of Arizona College of Public Health, and University of Arizona Cancer Center, Tucson, AZ, United States.
  • Carver College of Medicine, University of Iowa, Iowa City, IA, United States.
  • Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, WA, United States.

ORCID-Profile: Gloria D Coronado, Richard M Hoffman, Josheili Llavona-Ortiz, Carolyn M Rutter

Förderung

  • NCI NIH HHS
  • NIMHD NIH HHS
  • NIH HHS
  • National Cancer Institute
  • National Institute of Minority Health and Health Disparities
  • National Institutes of Health

Zitieren

APA

Coronado, G. D., Hoffman, R. M., Llavona-Ortiz, J., & Rutter, C. M. (2025). The Centers for Medicare and Medicaid Services and others misunderstand stool testing for colorectal cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf341

Vancouver

Coronado GD, Hoffman RM, Llavona-Ortiz J, Rutter CM. The Centers for Medicare and Medicaid Services and others misunderstand stool testing for colorectal cancer. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf341

BibTeX
@article{Coronado2025,
  author = {Coronado, Gloria D and Hoffman, Richard M and Llavona-Ortiz, Josheili and Rutter, Carolyn M},
  title = {The Centers for Medicare and Medicaid Services and others misunderstand stool testing for colorectal cancer},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djaf341}
}
Kostenlos starten →